Navigation Links
Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
Date:6/2/2008

.

About Genzyme

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 10,000 employees in locations spanning the globe and 2007 revenues of $3.8 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, cardiovascular disease, and other areas of unmet medical need.

This press release contains forward-looking statements, including statements regarding the potential administration, dosing and therapeutic benefit of Clolar in various cancer indications; the expected results of the data generated from the Clolar clinical trials; and the requirements and plans for regulatory filings and approvals for Clolar in additional indications. These risks and uncertainties include, among others, the timing of discussions with the FDA regarding clinical studies and approval of Clolar in additional indications; the timing and content of decisions by the FDA related to clinical trials and approval of Clolar in additional indications; the actual efficacy and safety of Clolar for the indications in which it is being tested; and the risks and uncertainties described in reports filed by Genzyme with the U.S. Securities and Exchange Commission, including without limitation t
'/>"/>

SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
3. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
4. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
5. Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
8. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
9. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
10. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
11. A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... China, Nov. 26, 2014 China Nepstar Chain ... "Company"), a leading retail drugstore chain in China based ... its unaudited financial results for the third quarter ended September ... 30, 2014: , Same store sales increased by ... , Revenue increased by 8.1% to RMB738.3 million (US$120.3 million) ...
(Date:11/24/2014)...  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today ... and update at the Piper Jaffray 26 th Annual ... Eastern Time (5:30 a.m. Pacific Time), at The New York ... A live audio webcast of the presentation will be ... www.arenapharm.com . A replay of the presentation will be ...
(Date:11/24/2014)... /PRNewswire/ - Milestone Pharmaceuticals, Inc. today announced data from a ... Melbourne, Australia of MSP-2017, a novel ... paroxysmal supraventricular tachycardia (PSVT).  The results demonstrated that ... at single doses up to and including 140 ... properties including rapid onset, and validating proof of ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3
... Oct. 5, 2011 Reportlinker.com announces ... is available in its catalogue: ... Dermatological Drugs, 7th Edition ... This Kalorama Information report details the ...
... Calif., Oct. 5, 2011 In an independent study ... the University of Texas Health Science Center San Antonio ... to compromised blood flow during reconstructive microsurgery when compared ... study by Dr. Cornejo and colleagues is important as ...
Cached Medicine Technology:The Market for Prescription Dermatological Drugs, 7th Edition 2The Market for Prescription Dermatological Drugs, 7th Edition 3The Market for Prescription Dermatological Drugs, 7th Edition 4The Market for Prescription Dermatological Drugs, 7th Edition 5The Market for Prescription Dermatological Drugs, 7th Edition 6The Market for Prescription Dermatological Drugs, 7th Edition 7The Market for Prescription Dermatological Drugs, 7th Edition 8The Market for Prescription Dermatological Drugs, 7th Edition 9The Market for Prescription Dermatological Drugs, 7th Edition 10The Market for Prescription Dermatological Drugs, 7th Edition 11The Market for Prescription Dermatological Drugs, 7th Edition 12The Market for Prescription Dermatological Drugs, 7th Edition 13The Market for Prescription Dermatological Drugs, 7th Edition 14The Market for Prescription Dermatological Drugs, 7th Edition 15Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery 2
(Date:11/26/2014)... Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 ... on sales(at)researchmoz(dot)us , Researchmoz.us announces a new research ... with deep study of the report on the diabetes ... sugar. The global glucose monitoring market has a growth ... of diabetics in the world. Their numbers have prompted ...
(Date:11/26/2014)... November 26, 2014 For those with a ... LES MILLS BODYPUMP™ classes at the University of ... workout they've been looking for. The 45- 60 minute classes ... Health and Wellness Center fitness club memberships. , LES MILLS ... are fast-paced and are aimed at fast results , ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Sonoran ... ANP-BC, recently received the Distinguished Preceptorship Award from ... for her role in the advancement of nurse ... of an individual who had made a significant ... NPs. The American Association of Nurse Practitioners (AANP) ...
(Date:11/26/2014)... News) -- Vultures have developed highly specialized ways of ... dead animals, researchers report. The new research investigated ... and in the guts of 50 turkey vultures and ... faces of the vultures had more than 500 different ... the study found. The findings suggest that a ...
(Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Exposure to peanut ... peanut allergy in infants with the skin condition eczema, ... school-aged children in the United States are allergic to ... to food allergies, particularly peanut allergy, the researchers noted. ... months to 15 months. The researchers examined the amount ...
Breaking Medicine News(10 mins):Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2
... ... Noni Fruit , ... (Vocus) May 19, 2010 -- Tahitian Noni International (TNI) has announced the creation ... company leaders have realized that noni is more than just a juice-and they are using ...
... ... Experience, View Their Photos, and Learn What Footwear To Pack for an African Safari , ... Seattle, Wash. (PRWEB) May 17, 2010 -- Good ... online shoe retailer before embarking on her honeymoon, vowing to pack only five pairs of shoes ...
... ... and young adults are ready for plastic surgery. , ... Voohees, NJ (Vocus) May 19, 2010 -- In light of recent media coverage of ... surgeon , Dr. Paul M. Parker, saw a great opportunity to address the right way to ...
... The neXante ... and xMM skin, respectively on Basal Cell Cancer, Squamous Cell Cancer, and Malignant Melanoma of ... only tracks and stores images of the skin, but also allows for recording the diagnosis, ... ...
... ... offers unique source of income for hard pressed primary care physicians. , ... Sacramento, CA (PRWEB) May 19, ... soon overwhelm private practice groups across the country with 31 million new patients. ...
... ... Angel Investors. , ... (PRWEB) May 19, 2010 -- SeniorHomes.com , an online directory and resource for ... it received a $1.1 million of Series A financing led by MentorTech Ventures of ...
Cached Medicine News:Health News:New Bioactive Beverages Available From Tahitian Noni International 2Health News:The Bachelor's Molly Malaney Blogs About Honeymoon at Onlineshoes.com 2Health News:The Bachelor's Molly Malaney Blogs About Honeymoon at Onlineshoes.com 3Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 2Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 3Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 4Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 5Health News:neXante Turns Apple's iPhone Into Skin Cancer Surveillance Support Tool And Health Record 2Health News:Physicians Preferred Wellness Group Receives Prestigious MD Preferred Service Award 2Health News:SeniorHomes.com Closes $1.1 Million Series A Round of Investment Financing 2
The Fathom Guidewire combines a nitinol hypotube distal segment with advanced microfabrication technology, creating a design that revolutionizes access of the most tortuous vasculature....
... for stent delivery. Uses perpendicular applied ... Allows user to adjust stent position ... tactile feel via fine adjustment and ... visualization at any angle. The Cordis ...
Vial with 100 Urine Reagent Test Strips, tests for glucose, protein, pH, blood, ketone, bilirubin, nitrite, urobilinogen, specific gravity. FOR LABORATORY USE BY QUALIFIED TECHNICIANS....
... the latest from Quality Mapping Solutions, ... designed specifically for implementing and managing ... superior design, functionality, security, and versatility ... managing a quality program., ,Based upon ...
Medicine Products: